Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Metformin can cause hair loss in some women with PCOS.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

Hirsutism in teen girls is common, usually harmless, but can sometimes signal serious issues and is treatable.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

New treatments for male hypogonadism are effective and should be personalized.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.